메뉴 건너뛰기




Volumn 6, Issue 3, 2013, Pages 226-233

Anti-VEGFA Therapy Reduces Tumor Growth and Extends Survival in a Murine Model of Ovarian Granulosa Cell Tumor

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 2;

EID: 84878688768     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.13136     Document Type: Article
Times cited : (15)

References (48)
  • 3
    • 0037445186 scopus 로고    scopus 로고
    • Granulosa cell tumor of the ovary
    • Schumer ST and Cannistra SA (2003). Granulosa cell tumor of the ovary. J Clin Oncol 21, 1180-1189.
    • (2003) J Clin Oncol , vol.21 , pp. 1180-1189
    • Schumer, S.T.1    Cannistra, S.A.2
  • 5
    • 77953375611 scopus 로고    scopus 로고
    • Prognostic factors in adult granulosa cell tumors of the ovary: A retrospective analysis of 80 cases
    • Ayhan A, Salman MC, Velipasaoglu M, Sakinci M, and Yuce K (2009). Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases. J Gynecol Oncol 20, 158-163.
    • (2009) J Gynecol Oncol , vol.20 , pp. 158-163
    • Ayhan, A.1    Salman, M.C.2    Velipasaoglu, M.3    Sakinci, M.4    Yuce, K.5
  • 6
    • 0030003603 scopus 로고    scopus 로고
    • Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: Mitotic count and Ki-67 are indicators of poor prognosis
    • King LA, Okagaki T, Gallup DG, Twiggs LB, Messing MJ, and Carson LF (1996). Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis. Gynecol Oncol 61, 227-232.
    • (1996) Gynecol Oncol , vol.61 , pp. 227-232
    • King, L.A.1    Okagaki, T.2    Gallup, D.G.3    Twiggs, L.B.4    Messing, M.J.5    Carson, L.F.6
  • 7
    • 0030743165 scopus 로고    scopus 로고
    • Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes
    • Amsterdam A and Selvaraj N (1997). Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes. Endocr Rev 18, 435-461.
    • (1997) Endocr Rev , vol.18 , pp. 435-461
    • Amsterdam, A.1    Selvaraj, N.2
  • 8
    • 0029932105 scopus 로고    scopus 로고
    • Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: A case report and review of the literature
    • Hines JF, Khalifa MA, Moore JL, Fine KP, Lage JM, and Barnes WA (1996). Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: a case report and review of the literature. Gynecol Oncol 60, 484-488.
    • (1996) Gynecol Oncol , vol.60 , pp. 484-488
    • Hines, J.F.1    Khalifa, M.A.2    Moore, J.L.3    Fine, K.P.4    Lage, J.M.5    Barnes, W.A.6
  • 10
    • 84857837160 scopus 로고    scopus 로고
    • Molecular pathogenesis of granulosa cell tumors of the ovary
    • Jamieson S and Fuller PJ (2012). Molecular pathogenesis of granulosa cell tumors of the ovary. Endocr Rev 33, 109-144.
    • (2012) Endocr Rev , vol.33 , pp. 109-144
    • Jamieson, S.1    Fuller, P.J.2
  • 12
    • 0028052989 scopus 로고
    • Granulosa cell tumors of the ovary: Prognostic factors and outcome
    • Malmstrom H, Hogberg T, Risberg B, and Simonsen E (1994). Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol 52, 50-55.
    • (1994) Gynecol Oncol , vol.52 , pp. 50-55
    • Malmstrom, H.1    Hogberg, T.2    Risberg, B.3    Simonsen, E.4
  • 13
    • 84862819234 scopus 로고    scopus 로고
    • Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary
    • Park JY, Jin KL, Kim DY, Kim JH, Kim YM, Kim KR, Kim YT, and Nam JH (2012). Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecol Oncol 125, 80-86.
    • (2012) Gynecol Oncol , vol.125 , pp. 80-86
    • Park, J.Y.1    Jin, K.L.2    Kim, D.Y.3    Kim, J.H.4    Kim, Y.M.5    Kim, K.R.6    Kim, Y.T.7    Nam, J.H.8
  • 15
    • 84856305309 scopus 로고    scopus 로고
    • Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: Brief report and review of the literature
    • Alhilli MM, Long HJ, Podratz KC, and Bakkum-Gamez JN (2012). Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: brief report and review of the literature. J Obstet Gynaecol Res 38, 340-344.
    • (2012) J Obstet Gynaecol Res , vol.38 , pp. 340-344
    • Alhilli, M.M.1    Long, H.J.2    Podratz, K.C.3    Bakkum-Gamez, J.N.4
  • 16
    • 84864011864 scopus 로고    scopus 로고
    • Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: Case report
    • Raspagliesi F, Martinelli F, Grijuela B, and Guadalupi V (2011). Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: case report. J Obstet Gynaecol Res 37, 1864-1867.
    • (2011) J Obstet Gynaecol Res , vol.37 , pp. 1864-1867
    • Raspagliesi, F.1    Martinelli, F.2    Grijuela, B.3    Guadalupi, V.4
  • 17
  • 18
    • 83155168437 scopus 로고    scopus 로고
    • Serum vascular endothelial growth factor A (VEGF) is elevated in patients with ovarian granulosa cell tumor (GCT), and VEGF inhibition by bevacizumab induces apoptosis in GCT in vitro
    • Farkkila A, Pihlajoki M, Tauriala H, Butzow R, Leminen A, Unkila-Kallio L, Heikinheimo M, and Anttonen M (2011). Serum vascular endothelial growth factor A (VEGF) is elevated in patients with ovarian granulosa cell tumor (GCT), and VEGF inhibition by bevacizumab induces apoptosis in GCT in vitro. J Clin Endocrinol Metab 96, E1973-E1981.
    • (2011) J Clin Endocrinol Metab , vol.96
    • Farkkila, A.1    Pihlajoki, M.2    Tauriala, H.3    Butzow, R.4    Leminen, A.5    Unkila-Kallio, L.6    Heikinheimo, M.7    Anttonen, M.8
  • 19
    • 34447108810 scopus 로고    scopus 로고
    • Vascular endothelial growth factor: Biology and therapeutic applications
    • Ho QT and Kuo CJ (2007). Vascular endothelial growth factor: biology and therapeutic applications. Int J Biochem Cell Biol 39, 1349-1357.
    • (2007) Int J Biochem Cell Biol , vol.39 , pp. 1349-1357
    • Ho, Q.T.1    Kuo, C.J.2
  • 20
    • 70350655979 scopus 로고    scopus 로고
    • VEGF as an inhibitor of tumor vessel maturation: Implications for cancer therapy
    • Greenberg JI and Cheresh DA (2009). VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy. Expert Opin Biol Ther 9, 1347-1356.
    • (2009) Expert Opin Biol Ther , vol.9 , pp. 1347-1356
    • Greenberg, J.I.1    Cheresh, D.A.2
  • 21
    • 0037699954 scopus 로고    scopus 로고
    • The biology of VEGF and its receptors
    • Ferrara N, Gerber HP, and LeCouter J (2003). The biology of VEGF and its receptors. Nat Med 9, 669-676.
    • (2003) Nat Med , vol.9 , pp. 669-676
    • Ferrara, N.1    Gerber, H.P.2    LeCouter, J.3
  • 22
    • 77954385088 scopus 로고    scopus 로고
    • Direct survival role of vascular endothelial growth factor (VEGF) on rat ovarian follicular cells
    • Irusta G, Abramovich D, Parborell F, and Tesone M (2010). Direct survival role of vascular endothelial growth factor (VEGF) on rat ovarian follicular cells. Mol Cell Endocrinol 325, 93-100.
    • (2010) Mol Cell Endocrinol , vol.325 , pp. 93-100
    • Irusta, G.1    Abramovich, D.2    Parborell, F.3    Tesone, M.4
  • 23
    • 34848865001 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF) suppresses ovarian granulosa cell apoptosis in vitro
    • Kosaka N, Sudo N, Miyamoto A, and Shimizu T (2007). Vascular endothelial growth factor (VEGF) suppresses ovarian granulosa cell apoptosis in vitro. Biochem Biophys Res Commun 363, 733-737.
    • (2007) Biochem Biophys Res Commun , vol.363 , pp. 733-737
    • Kosaka, N.1    Sudo, N.2    Miyamoto, A.3    Shimizu, T.4
  • 24
    • 2542490291 scopus 로고    scopus 로고
    • Vascular endothelial growth factor and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle
    • Greenaway J, Connor K, Pedersen HG, Coomber BL, LaMarre J, and Petrik J (2004). Vascular endothelial growth factor and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle. Endocrinology 145, 2896-2905.
    • (2004) Endocrinology , vol.145 , pp. 2896-2905
    • Greenaway, J.1    Connor, K.2    Pedersen, H.G.3    Coomber, B.L.4    LaMarre, J.5    Petrik, J.6
  • 29
    • 33745923690 scopus 로고    scopus 로고
    • Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer
    • Monk BJ, Han E, Josephs-Cowan CA, Pugmire G, and Burger RA (2006). Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer. Gynecol Oncol 102, 140-144.
    • (2006) Gynecol Oncol , vol.102 , pp. 140-144
    • Monk, B.J.1    Han, E.2    Josephs-Cowan, C.A.3    Pugmire, G.4    Burger, R.A.5
  • 31
    • 56449083159 scopus 로고    scopus 로고
    • The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: A case report
    • Kesterson JP, Mhawech-Fauceglia P, and Lele S (2008). The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: a case report. Gynecol Oncol 111, 527-529.
    • (2008) Gynecol Oncol , vol.111 , pp. 527-529
    • Kesterson, J.P.1    Mhawech-Fauceglia, P.2    Lele, S.3
  • 32
    • 78650234556 scopus 로고    scopus 로고
    • Neoadjuvant bevacizumab in a granulosa cell tumor of the ovary: A case report
    • Barrena Medel NI, Herzog TJ, Wright JD, and Lewin SN (2010). Neoadjuvant bevacizumab in a granulosa cell tumor of the ovary: a case report. Anticancer Res 30, 4767-4768.
    • (2010) Anticancer Res , vol.30 , pp. 4767-4768
    • Barrena Medel, N.I.1    Herzog, T.J.2    Wright, J.D.3    Lewin, S.N.4
  • 34
    • 84859415438 scopus 로고    scopus 로고
    • Minireview: Animal models and mechanisms of ovarian cancer development
    • Mullany LK and Richards JS (2012). Minireview: animal models and mechanisms of ovarian cancer development. Endocrinology 153, 1585-1592.
    • (2012) Endocrinology , vol.153 , pp. 1585-1592
    • Mullany, L.K.1    Richards, J.S.2
  • 38
    • 18144364695 scopus 로고    scopus 로고
    • The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors
    • Brown J, Shvartsman HS, Deavers MT, Ramondetta LM, Burke TW, Munsell MF, and Gershenson DM (2005). The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol 97, 489-496.
    • (2005) Gynecol Oncol , vol.97 , pp. 489-496
    • Brown, J.1    Shvartsman, H.S.2    Deavers, M.T.3    Ramondetta, L.M.4    Burke, T.W.5    Munsell, M.F.6    Gershenson, D.M.7
  • 40
    • 0034531952 scopus 로고    scopus 로고
    • MAP kinases and hypoxia in the control of VEGF expression
    • Berra E, Pages G, and Pouyssegur J (2000). MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev 19, 139-145.
    • (2000) Cancer Metastasis Rev , vol.19 , pp. 139-145
    • Berra, E.1    Pages, G.2    Pouyssegur, J.3
  • 42
    • 33646758105 scopus 로고    scopus 로고
    • Role of vascular endothelial growth factor in ovarian physiology-an overview
    • Kaczmarek MM, Schams D, and Ziecik AJ (2005). Role of vascular endothelial growth factor in ovarian physiology-an overview. Reprod Biol 5, 111-136.
    • (2005) Reprod Biol , vol.5 , pp. 111-136
    • Kaczmarek, M.M.1    Schams, D.2    Ziecik, A.J.3
  • 43
    • 67649814136 scopus 로고    scopus 로고
    • PI3K/PTEN signaling in angiogenesis and tumorigenesis
    • Jiang BH and Liu LZ (2009). PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 102, 19-65.
    • (2009) Adv Cancer Res , vol.102 , pp. 19-65
    • Jiang, B.H.1    Liu, L.Z.2
  • 45
    • 0031898292 scopus 로고    scopus 로고
    • Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo
    • Borgström P, Bourdon MA, Hillan KJ, Sriramarao P, and Ferrara N (1998). Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. Prostate 35, 1-10.
    • (1998) Prostate , vol.35 , pp. 1-10
    • Borgström, P.1    Bourdon, M.A.2    Hillan, K.J.3    Sriramarao, P.4    Ferrara, N.5
  • 46
    • 3042548695 scopus 로고    scopus 로고
    • Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts
    • Inai T, Mancuso M, Hashizume H, Baffert F, Haskell A, Baluk P, Hu-Lowe DD, Shalinsky DR, Thurston G, Yancopoulos GD, et al. (2004). Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 165, 35-52.
    • (2004) Am J Pathol , vol.165 , pp. 35-52
    • Inai, T.1    Mancuso, M.2    Hashizume, H.3    Baffert, F.4    Haskell, A.5    Baluk, P.6    Hu-Lowe, D.D.7    Shalinsky, D.R.8    Thurston, G.9    Yancopoulos, G.D.10
  • 48
    • 11844254414 scopus 로고    scopus 로고
    • Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
    • Jain RK (2005). Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62.
    • (2005) Science , vol.307 , pp. 58-62
    • Jain, R.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.